Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
34m agoPennant Announces First Quarter 2026 Earnings Release and Call
35m agoMacquarie Australia Conference Presentation
1h agoIn HelloNation, Luxury Real Estate Expert Saber Cofer Explains Luxury Living in Amarillo Offers Space, Style, and Value
1h agoFCPT Announces Acquisition of a Belle Tire Property for $2.4 Million
1h agoSherritt Provides a Corporate Update
Monopar Therapeutics Inc. logo

Monopar Therapeutics Inc.

About

Monopar Therapeutics Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 19 2026
Monopar Presents Phase 3 Data Showing Greater Neurologic Benefit with ALXN1840 vs SoC in Wilson Disease Patients with Neurologic Symptoms at AAN 2026
Mar 27 2026
Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
Mar 2 2026
Monopar Expands Leadership Team with Appointment of Seasoned Biopharma Executive Susan Rodriguez as Chief Commercial and Strategy Officer
Nov 13 2025
Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments
Nov 9 2025
Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025
Case study
How Monopar Therapeutics Inc. runs its investor program on 6ix — audience, formats, and program overview.

Community Chat

Ask AI

6ix6ix